Anima Biotech
Tel Aviv, Israel· Est.
AI‑powered visual biology platform that enables autonomous hypothesis testing inside cells for drug discovery.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑powered visual biology platform that enables autonomous hypothesis testing inside cells for drug discovery.
NeurologyOncologyImmunology
Technology Platform
Biology GPU – a visual biology runtime that enables AI models to execute and interpret high‑throughput cellular experiments, closing the loop between hypothesis generation and functional validation.
Opportunities
Scaling the Biology GPU across additional therapeutic areas and expanding partnership contracts with pharma could drive significant revenue and market adoption.
Risk Factors
Technical validation of AI‑generated biological insights at scale and dependence on large pharma partnerships pose execution and market risks.
Competitive Landscape
Competes with AI‑driven discovery firms like Insilico Medicine, Recursion, and Atomwise, but differentiates through its visual biology runtime that provides experimental feedback rather than purely computational predictions.